Exclusive Summary

• A superior solution for the synthetic opioid crisis: Its >10x longer duration of action versus naloxone effectively counteracts potent, long-acting opioids like fentanyl, preventing re-narcosis and reducing monitoring costs.
• "Gold-standard" quality endorsement with US-FDA approval: Holding US-FDA GMP certification serves as a "quality passport," enabling accelerated registration and market access in numerous countries worldwide.
• Favorable "blue ocean" market opportunity: Compared to the highly commoditized naloxone, the generic nalmefene market has limited competitors, offering partners a differentiated, higher-margin strategic product.